Professor of Medicine Thoracic Oncology UCSF-Helen Diller Family Comprehensive Cancer Center

Oncology

Dr. Thierry M. Jahan works in the field of Oncology. He went to George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care He received 4 awards: "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors", "America's Top Doctors for Cancer" and "Top MD". Doctor Thierry M. Jahan, MD is a published doctor and has 39 publications published. The lastest was: 'Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.' He accepts Medicare.

Publications

---

• Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung Cancer.
• A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non-Small-Cell Lung Can...
• The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung Cancer.
• Aggressive and minimally invasive surgery for pulmonary metastasis of Sarcoma.
• Divergent Management Strategies for Typical Versus Atypical Carcinoid Tumors of the Thoracic Cavity.
• Determination of Cutpoints for Low and High Number of Symptoms in Patients with Advanced Cancer.
• One size does not fit all lung Cancer patients.
• Impact of Age and Comorbidity on Non-Small-Cell Lung Cancer Treatment in Older Veterans.
• Malignant pleural mesothelioma. Clinical practice guidelines in oncology.
• Implications of Delayed Initiation of Radiotherapy: Accelerated Repopulation after Induction Chemotherapy for Stage III Non-small Cell Lung Cancer.
• Lung Cancer stigma, depression, and quality of life among ever and never smokers.
• Measuring stigma in people with lung Cancer: psychometric testing of the cataldo lung Cancer stigma scale.
• A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies.
• Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung Cancer.
• Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung Cancer.
• Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung Cancer: clinical...
• Malignant pheochromocytomas and paraganGliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
• Unusual thoracic problems in patients with malignancies: case 3. Carcinoid tumor of the thymus.
• Mechanisms of and potential treatment strategies for metastatic disease in non-small cell lung Cancer.
• Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for Malignant pleural mesothelioma.
• Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung Cancer (NSCLC): results from a prospective analysis using the Lung Cancer S...
• A review of the prevalence and impact of multiple symptoms in oncology patients.
• Changes in symptom clusters in patients undergoing radiation therapy.
• Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory l...
• Non-small cell lung Cancer clinical practice guidelines in oncology.
• Small cell lung Cancer clinical practice guidelines in oncology.
• A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced Cancer.
• Emerging antiangiogenic therapies for non-small-cell lung Cancer.
• Differences in symptom clusters identified using occurrence rates versus symptom severity ratings in patients at the end of radiation therapy.
• Non-small cell lung Cancer.
• Thymic malignancies.
• Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.
• Treatment of metastatic Cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
• Stage II (N1) lung Cancer.
• Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung Cancer.
• Resection and IORT followed by three-dimensional conformal radiotherapy with or without adjuvant chemotherapy for Malignant mesothelioma.
• NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.
• A phase I trial of panobinostat and epirubicin in solid Tumors with a dose expansion in patients with sarcoma.

Schools

---

• George Washington University School Of Medicine

• Cedars Sinai Med Center

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• Bladder Cancer
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• America's Top Doctors
• America's Top Doctors for Cancer
• Top MD

Education

---

• Cedars-Sinai Medical Center
• George Washington University School of Medicine

Hospital

---

• San Francisco General Hospital and Trauma Center
• UCSF Medical Center

Drug Facts

---

NPI NUMBER		1427007657
NPPES Provider LastName		JAHAN
NPPES Provider FirstName		THIERRY
NPPES Provider ZIPCode		941153010
NPPES Provider State		CA
Specialty Description		Medical Oncology
Total Claim Count		443.0
Distinct Opioid Count		3.0
Opioid Claim Count		58.0
Percent Opioid Claims		13.09

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1427007657
Last Name Of The Provider	JAHAN
First Name Of The Provider	THIERRY
View All

Similar Doctors

---

	Dr. Jeffrey L. Wolf, MD This Doctor is OpenDoctor Recommended.
	Dr. Bertrand Y. Tuan, MD This Doctor is OpenDoctor Recommended.
	Dr. Collin M. Blakely, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark M. Moasser, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ari D. Baron, MD This Doctor is OpenDoctor Recommended.
	Dr. Joan E. Etzell, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew C. Hsieh, MD This Doctor is OpenDoctor Recommended.
	Dr. Isaac C. Henderson, MD This Doctor is OpenDoctor Recommended.
	Dr. Derek Kerr, MD This Doctor is OpenDoctor Recommended.
	Dr. Marc A. Shuman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Margaret A. Tempero, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew H. Ko, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jennifer L. Caswell, MD
	Dr. Judy M. Cheng, MD This Doctor is OpenDoctor Recommended.
	Dr. James M. Kahn, DO
	Dr. Sue Kim, MD
	Dr. Frank A. Scappaticci, MD This Doctor is OpenDoctor Recommended.
	Dr. Melisa L. Wong, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog